Technology transfer showcase

Features on projects supported by Technology Transfer that have brought a product to market or have attracted a follow-on funder.

Strategic Translation Award Fighting to end tuberculosis

Dr Helen McShane at the University of Oxford and the Oxford-Emergent Tuberculosis Consortium Ltd are trialling the efficacy of a new TB vaccine candidate in South African infants.

Watch (4 min 53 s)

Strategic Translation Award Developing diagnostic tests for infectious diseases

Test kits developed by Diagnostics for the Real World could transform the diagnosis of chlamydia and other common infections.

Watch (7 min 22s)

Blocking BRAF Developing enzyme inhibitors as cancer drugs

How Trust-supported work at the Institute for Cancer Research, London could lead to a new drug to fight melanoma and other cancers.

Watch (4 min 13 s)

Strategic Translation Award Typhoid vaccine

Emergent BioSolutions has developed a single-dose, drinkable typhoid vaccine candidate that has shown considerable promise in phase II studies.

Strategic Translation Award Genetic studies A new technology being developed by Population Genetics Technologies could slash the costs of genetic studies that sift the entire human genome for disease-predisposing genes.

Learning curve Video laryngoscope

Matt McGrath demonstrates his hugely successful innovation.

Watch (5 min 53 s)

From start-up to big business Taking science to market The founders of DanioLabs and Paradigm Therapeutics - two biotech companies backed by Wellcome Trust funding - explain how they became science entrepreneurs.

Seeding Drug Discovery Natural appetite suppression A hormone found naturally in the gut is the basis of a new drug to tackle obesity.